STAT5A and ovarian carcinoma: Compared to the low-risk group with STAT1,4, the high-risk group with STAT5A was closely linked with a worse 1-, 2-, 5- years DSS of ovarian cancer patients (median time=3.4 vs. 4.7 years, HR =1.831, P = 3.31e-05 in Figure S2).